Skip to main content
. 2017 Nov 1;19(11):623–632. doi: 10.1089/dia.2017.0165

Table 1.

Demographic Data at Study Entrance Randomized Patients

  Intervention (N = 61) Controls (N = 62) P
Age (year), mean ± SD 52.8 ± 15.1 51.4 ± 16.4 0.6145
Men, N (%) 40 (65.6) 47 (75.8) 0.2142
BMI (kg/m2), mean ± SD 28.4 ± 6.1 28.7 ± 6.0 0.7947
 <18.5, N (%) 0 (0.0) 1 (1.6) 0.6838
 18.5–24.9, N (%) 19 (31.1) 19 (30.6)  
 25.0–29.9, N (%) 19 (31.1) 23 (37.1)  
 ≥30, N (%) 23 (37.8) 19 (30.7)  
 30.0–34.9 (obesity class I), N (%) 14 (23.0) 9 (14.5)  
 35.0–39.9 (obesity class II), N (%) 7 (11.5) 6 (9.7)  
 ≤40 (obesity class III), N (%) 2 (3.3) 4 (6.5)  
Age at diagnosis (year), mean ± SD 33.0 ± 16.1 34.6 ± 16.4 0.5929
Years with DM, mean ± SD 19.8 ± 11.5 16.3 ± 9.2 0.0707
Type of diabetes, N (%)     0.6466
 Type 1 34 (55.7) 32 (51.6)  
 Type 2 27 (44.3) 30 (48.4)  
Years injecting insulin (N = 118), mean ± SD 14.8 ± 12.8 12.5 ± 10.0 0.2652
Years injecting insulin, N (%)     0.0678
 ≤3 years 4 (6.6) 11 (17.7)  
 >3 years 57 (93.4) 51 (82.3)  
Latest HbA1c at study entry (%), mean ± SD 8.3 ± 1.7 8.5 ± 1.8 0.6207
Presence of LH found by investigators, N (%) 61 (100.0) 62 (100.0) 1
Patients who knew they had LH?, N (%) 41 (71.9) 45 (73.8) 0.8222
Patient has received IT training in the past?, N (%)     0.1191
 Yes 58 (95.1) 52 (83.9)  
 No 2 (3.3) 6 (9.7)  
 Don't know 1 (1.6) 4 (6.5)  
When was last IT training?, N (%)     0.915
 Less than 6 months ago 5 (8.2) 8 (13.1)  
 Between 6 and 12 months ago 9 (14.8) 9 (14.8)  
 Between 1 and 5 years ago 21 (34.4) 17 (27.9%)  
 Between 6 and 10 years ago 21 (34.4) 17 (27.9)  
 None recorded 5 (8.2) 10 (16.4)  
Number of injections/day, N (%)     0.3032
 1 4 (7.0) 5 (8.2)  
 2 6 (10.5) 7 (11.5)  
 3 2 (3.5) 7 (11.5)  
 4 38 (66.7) 36 (59.0)  
 5 6 (10.5) 5 (8.2)  
 >5 1 (1.8) 1 (1.6)  

BMI, body mass index; DM, diabetes mellitus; IT, injection technique; LH, lipohypertrophy.